Takeda OTC Stock Today

TKPHF -  USA Stock  

USD 33.61  0.18  0.54%

Takeda Pharmaceutica is trading at 33.61 as of the 3rd of August 2021, a 0.54 percent up since the beginning of the trading day. The stock's lowest day price was 33.61. Takeda Pharmaceutica has 49 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Takeda Pharmaceutica are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of January 2021 and ending today, the 3rd of August 2021. Click here to learn more.
 Market Performance
1 of 100
  Odds Of Distress
Less than 49
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Takeda Pharmaceutica OTC Stock Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47099 people. more on Takeda Pharmaceutica
Latest headline from seekingalpha.com: Takeda Pharmaceutical 5 percent Dividend Yield With Bullish Catalysts This Year - Seeking Alpha
Legal NameTakeda Pharmaceutica
CEOChristophe Weber  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Takeda Pharmaceutica's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldFairly Valued
Takeda Pharmaceutica [TKPHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 52.68 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutica's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Takeda Pharmaceutica classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 1.58 B outstanding shares. Takeda Pharmaceutica has accumulated about 1000 B in cash with 1010 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 641.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Takeda Pharmaceutica Probability Of Bankruptcy
Takeda Pharmaceutica maintains a total of 1.58 Billion outstanding shares. 30% of Takeda Pharmaceutica outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Takeda Ownership Details

Takeda Stock Price Odds Analysis

What are Takeda Pharmaceutica's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Takeda Pharmaceutica jumping above the current price in 90 days from now is about 61.65%. The Takeda Pharmaceutica probability density function shows the probability of Takeda Pharmaceutica otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Takeda Pharmaceutica has a beta of 0.3275. This usually implies as returns on the market go up, Takeda Pharmaceutica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Takeda Pharmaceutica will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Takeda Pharmaceutica is significantly underperforming DOW.
 Odds Down 33.61HorizonTargetOdds Up 33.61 
37.72%90 days
Based on a normal probability distribution, the odds of Takeda Pharmaceutica to move above the current price in 90 days from now is about 61.65 (This Takeda Pharmaceutica probability density function shows the probability of Takeda OTC Stock to fall within a particular range of prices over 90 days) .

Takeda Pharmaceutica Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Takeda Pharmaceutica market risk premium is the additional return an investor will receive from holding Takeda Pharmaceutica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Takeda Pharmaceutica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Takeda Pharmaceutica's alpha and beta are two of the key measurements used to evaluate Takeda Pharmaceutica's performance over the market, the standard measures of volatility play an important role as well.

Takeda Stock Against Markets

Picking the right benchmark for Takeda Pharmaceutica otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Takeda Pharmaceutica otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Takeda Pharmaceutica is critical whether you are bullish or bearish towards Takeda Pharmaceutica at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Takeda Pharmaceutica without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now


Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Takeda Pharmaceutica Corporate Directors

Takeda Pharmaceutica corporate directors refer to members of a Takeda Pharmaceutica board of directors. The board of directors generally takes responsibility for the Takeda Pharmaceutica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Takeda Pharmaceutica's board members must vote for the resolution. The Takeda Pharmaceutica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Emiko Azuma - Independent DirectorProfile
Toshiyuki Shiga - Independent DirectorProfile
Masato Iwasaki - Chief Director of Pharmaceutical Sales, DirectorProfile
Masahiro Sakane - Independent DirectorProfile
Additionally, take a look at World Market Map. Note that the Takeda Pharmaceutica information on this page should be used as a complementary analysis to other Takeda Pharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Takeda OTC Stock analysis

When running Takeda Pharmaceutica price analysis, check to measure Takeda Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutica is operating at the current time. Most of Takeda Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutica's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Takeda Pharmaceutica's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
The market value of Takeda Pharmaceutica is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutica's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutica underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine Takeda Pharmaceutica value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.